Ishares Msci Brazil ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? Ishares Msci Brazil ETF trades at $42.18 (market cap $13.14B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Ishares Msci Brazil ETF is far larger — about 7.3× Vir Biotechnology Inc. Common Stock's market cap, and Ishares Msci Brazil ETF is trading nearer its 52-week high, Vir Biotechnology Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Ishares Msci Brazil ETF for 50 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| EWZ | VIR | |
|---|---|---|
Market Cap | $13.14B | $1.80B |
Volume | 52,443,793 | 1,782,836 |
Sector | Broad Market / Factor | Health |
52-Week High | $43.54 | $11.78 |
52-Week Low | $29.24 | $5.12 |
Typical Hold Time | 50 Days | 0 Days |
Enterprise Value | — | $1.36B |
Signals from Pluang's Aura AI — not financial advice
EWZ, the iShares MSCI Brazil ETF, trades at $42.87, down 1.54% today, with a bullish technical signal driven by moving averages but showing overbought RSI levels. The ETF is attracting significant attention due to Brazil's upcoming October election, with institutional investors accumulating positions through call options. Recent news highlights EWZ as a diversification tool against U.S. tech concentration and potential beneficiary of Brazilian economic policies.
The outlook for EWZ hinges on Brazil's political election outcome and commodity trends, offering asymmetric upside but facing currency and political volatility risks. Wall Street positioning suggests optimism, though investors must weigh the ETF's higher expense ratio against alternatives like FLBR for Brazilian exposure.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWZ is a country-specific ETF that tracks the Brazilian equity market. It provides exposure to large and mid-sized companies in Brazil, with a heavy focus on financials and materials, including major names like Nu Holdings, Vale, and Itaú Unibanco.
Read more on EWZ →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →